# Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer

> **NCT00126165** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alberta Health services** · enrollment: 72 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** radiotherapy

## Key facts

- **NCT ID:** NCT00126165
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2011-08
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2012-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00126165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00126165, "Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00126165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*